These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 30961950

  • 1. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kwon BS, Lee JH, Koh Y, Kim WS, Song JW, Oh YM, Lee SD, Lee SW, Lee JS, Lim CM, Choi CM, Huh JW, Hong SB, Shim TS, Jo KW.
    Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
    [Abstract] [Full Text] [Related]

  • 2. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim OH, Chong YP, Shim TS, Jo KW.
    J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810
    [Abstract] [Full Text] [Related]

  • 3. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course.
    Hwang JA, Kim S, Jo KW, Shim TS.
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275170
    [Abstract] [Full Text] [Related]

  • 4. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
    Gochi M, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y.
    BMJ Open; 2015 Aug 05; 5(8):e008058. PubMed ID: 26246077
    [Abstract] [Full Text] [Related]

  • 5. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.
    Pan SW, Shu CC, Feng JY, Wang JY, Chan YJ, Yu CJ, Su WJ.
    Clin Infect Dis; 2017 Sep 15; 65(6):927-934. PubMed ID: 28541556
    [Abstract] [Full Text] [Related]

  • 6. The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Lee JK, Kim S, Chong YP, Lee HJ, Shim TS, Jo KW.
    Chest; 2024 Sep 15; 166(3):442-451. PubMed ID: 38508335
    [Abstract] [Full Text] [Related]

  • 7. Comparison of treatment outcomes between intermittent and daily regimens in non-cavitary nodular bronchiectatic-type Mycobacterium avium complex pulmonary disease in relation to sputum smear results: a retrospective cohort study.
    Jung J, Chong YP, Lee HJ, Shim TS, Jo K-W.
    Antimicrob Agents Chemother; 2023 Nov 15; 67(11):e0100323. PubMed ID: 37843254
    [Abstract] [Full Text] [Related]

  • 8. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW, Moon SM, Kim SY, Park HY, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.
    Antimicrob Agents Chemother; 2018 Feb 15; 62(2):. PubMed ID: 29203483
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K, Ohshima N, Kawashima M, Okuda K, Sato R, Nagai H, Matsui H, Ohta K.
    Respir Med; 2015 Oct 15; 109(10):1347-53. PubMed ID: 26365483
    [Abstract] [Full Text] [Related]

  • 10. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ, Wu TS, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2007 Aug 15; 40(4):342-8. PubMed ID: 17712469
    [Abstract] [Full Text] [Related]

  • 11. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE.
    Chest; 2014 Aug 15; 146(2):276-282. PubMed ID: 24457542
    [Abstract] [Full Text] [Related]

  • 12. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ.
    Respir Med; 2019 May 15; 151():1-7. PubMed ID: 31047103
    [Abstract] [Full Text] [Related]

  • 13. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
    Chae G, Park YE, Chong YP, Lee HJ, Shim TS, Jo KW.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0226121. PubMed ID: 35950842
    [Abstract] [Full Text] [Related]

  • 14. Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Han DW, Jo KW, Kim OH, Shim TS.
    Respir Med; 2021 Apr 20; 179():106340. PubMed ID: 33618079
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE.
    Semin Respir Crit Care Med; 2018 Jun 20; 39(3):351-361. PubMed ID: 30071550
    [Abstract] [Full Text] [Related]

  • 16. Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.
    Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ.
    Am J Respir Crit Care Med; 2015 Sep 15; 192(6):754-60. PubMed ID: 26068042
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim SJ, Park J, Lee H, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2014 Jun 15; 18(6):730-6. PubMed ID: 24903946
    [Abstract] [Full Text] [Related]

  • 18. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Min J, Park J, Lee YJ, Kim SJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2015 Oct 15; 19(10):1239-45. PubMed ID: 26459540
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T, Nakagawa T, Suzuki S, Namkoong H, Morimoto K, Ishii M, Kurashima A, Betsuyaku T, Ogawa K, Hasegawa N, Nontuberculous Mycobacteriosis Japan Research Consortium (NTM-JRC).
    J Infect Chemother; 2019 Mar 15; 25(3):218-221. PubMed ID: 30172726
    [Abstract] [Full Text] [Related]

  • 20. Serum Krebs von den Lungen-6 level in the disease progression and treatment of Mycobacterium avium complex lung disease.
    Asakura T, Kimizuka Y, Nishimura T, Suzuki S, Namkoong H, Masugi Y, Sato Y, Ishii M, Hasegawa N.
    Respirology; 2021 Jan 15; 26(1):112-119. PubMed ID: 32602203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.